Alerts

GlucoPro Insulin Syringes Voluntarily Recalled A voluntary nationwide recall of all GlucoPro Insulin Syringes (Nipro Medical Corporation) is underway, according to a US Food and Drug Administration (FDA) notification to healthcare professionals. The alert notes that syringes may have needles that detach from the syringe. “If the needle becomes detached …

Novo Nordisk’s Once A Day Victoza(R) Receives FDA Approval for Adults with Type 2 Diabetes. Sibutramine Contraindicated in Patients with a History of Cardiovascular Disease — Sibutramine, marketed as Meridia in the US by Abbott, is now contraindicated in patients with a history of cardiovascular disease, the FDA announced. FDA …

2nd DPP-4 inhibitor gets FDA Approval Onglyza™ (saxagliptin) a new DPP-4 inhibitor similar to Januvia will give physicians another option in treating their patients with diabetes. See This Week’s Item #1.

New Insulin Patch gets FDA Approval A new mini tubeless insulin infusion patch will go on sale in the U.S.. See this week’s new product information and check out This Week’s Item #4.

New NIH Study Results Show Intensive Control Reduces Complications by More Than 50% – See This Week’s Item #1

Medtronic Diabetes is voluntarily recalling Quick-set® infusion sets that have lot numbers starting with the number “8”. These infusion sets are used with MiniMed Paradigm® Insulin Pumps. The action was taken because of a situation related to the tubing connector which may not allow the insulin pump to vent properly. …

POSSIBLE LINK BETWEEN INSULIN GLARGINE AND CANCER QUESTIONED –  MORE RESEARCH REQUIRED Experts stress patients should not stop using insulin and consult their doctor if concerned.  See This Week’s Item 1 Takeda’s Diabetes Drug Alogliptin Rejected by FDA  Asia’s biggest drugmaker, Takeda, failed to gain U.S. regulatory approval to market …

Controlling blood sugars may not be enough to prevent the complications of diabetes.   See this week’s Item 6

The FDA has informed us that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc., are being sold in the U.S. market. They may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use …

ADA confirms that the A1c test will be used for the diagnosis of diabetes. Fasting blood sugar tests will no longer be necessary to diagnosis diabetes. The A1c test can be done anytime without regard to meals. ADA – International Expert Committee Recommends A1c Test to Diagnose Diabetes